Prevention of group A streptococcal disease in the developing world: investigating innovative control strategies for rheumatic heart disease and impetigo

发展中国家 A 组链球菌疾病的预防：研究风湿性心脏病和脓疱病的创新控制策略

• 批准号: nhmrc : 1014431
• 负责人: Prof Andrew Steer
• 金额: $ 11.91万
• 依托单位: The University of Melbourne
• 依托单位国家: 澳大利亚
• 项目类别: Early Career Fellowships
• 财政年份: 2011
• 资助国家: 澳大利亚
• 起止时间: 2011-01-01 至 2012-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/prevention-group-streptococcal-disease-impetigo/109755
• 关键词: Prevention; group; streptococcal; disease; developing

Group A streptococcal diseases, including rheumatic heart disease and impetigo, are major causes of illness globally, mostly in developing countries. This proposal is a comprehensive investigation into new ways of curbing these diseases, including using ultrasound screening for rheumatic heart disease, community wide treatment for impetigo and laboratory testing for new vaccines. The studies will be done in Fiji and will be relevant for other developing countries and for Indigenous Australians.

A组链球菌疾病，包括风湿性心脏病和脓疱疮，是全球疾病的主要原因，主要发生在发展中国家。这项建议是对控制这些疾病的新方法的全面调查，包括使用超声筛查风湿性心脏病，脓疱疮的社区广泛治疗和新疫苗的实验室测试。这些研究将在斐济进行，并将与其他发展中国家和澳大利亚土著有关。